Approval · Notice of Compliance 26027 · 2021
TECARTUS: Notice of Compliance 26027
Issued June 8, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26027
- Date
- June 8, 2021
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TECARTUS | 02516667 | Marketed |
Medicinal ingredients
- BREXUCABTAGENE AUTOLEUCEL 2,000,000 CELLS per BAG